REQUEST A DEMO
Total
USD $0.00
Search more companies

Borola OOD (Bulgaria)

Main Activities: All Other Miscellaneous Food Manufacturing
Full name: Borola OOD Profile Updated: September 08, 2023
Buy our report for this company USD 29.95 Most recent financial data: 2021 Available in: English Download a sample report

Healthcare company Borola was established in 1996. The firm is primarily engaged in wholesaling pharmaceutical products. It is also active in the manufacture and trade in food supplements. Borola is an official distributor of Pharma Swiss, LEO Pharmaceutocal Products, For Tuniqne, Capsugel and Gerresheimer for Bulgaria.

Headquarters
ul. Tsar Simeon 52
Sofia; Sofia - city; Postal Code: 1202

Contact Details: Purchase the Borola OOD report to view the information.

Website: http://www.borola.com

Basic Information
Total Employees:
Purchase the Borola OOD report to view the information.
Outstanding Shares:
Purchase the Borola OOD report to view the information.
Registered Capital:
Purchase the Borola OOD report to view the information.
Financial Auditors:
Purchase the Borola OOD report to view the information.
Incorporation Date:
June 28, 1996
Key Executives
Purchase this report to view the information.
Manager
Purchase this report to view the information.
Manager
Purchase this report to view the information.
Procurator
Ownership Details
Purchase this report to view the information.
50%
Purchase this report to view the information.
50%
Company Performance
Financial values in the chart are available after Borola OOD report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency BGN. Absolute financial data is included in the purchased report.
Net sales revenue
5.92%
Total operating revenue
2.48%
Operating profit (EBIT)
-16.19%
EBITDA
-13.82%
Net Profit (Loss) for the Period
-18.07%
Total assets
-1.4%
Total equity
11.61%
Operating Profit Margin (ROS)
-5.88%
Net Profit Margin
-5.25%
Return on Equity (ROE)
-5.35%
Debt to Equity Ratio
-29.29%
Quick Ratio
0.06%
Cash Ratio
0.06%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?